Promising effect of Magliasa, a traditional Iranian formula, on experimental colitis on the basis of biochemical and cellular findings

Table 3 Macroscopic and microscopic scores as criteria for assessing colonic damage

Group	Macroscopic score		Microscopic score
	mean ± SE	Median (range)	mean ± SE	Median (range)
Sham	0.00 ± 0.00	0 (0-0)	0.00 ± 0.00	0 (0-0)
Control	3.40 ± 0.24a	3 (3-4)	4.00 ± 0.32a	4 (3-5)
Dexa	0.33 ± 0.21c	0 (0-1)	0.67 ± 0.21c	1 (0-1)
Inf	0.83 ± 0.31c	1 (0-2)	1.50 ± 0.34c	1 (1-3)
Mag-50	2.20 ± 0.37aeg	2 (1-3)	2.60 ± 0.51ae	3 (1-4)
Mag-100	1.80 ± 0.58ace	1 (1-4)	2.40 ± 0.75a	2 (1-5)
Mag-200	1.20 ± 0.20c	1 (1-2)	1.60 ± 0.40c	1 (1-3)

^aP < 0.05 vs Sham group;

^cP < 0.05 vs the control group;

^eP < 0.05 vs the dexamethasone group;

^gP < 0.05 vs the infliximab group. Dexa: Dexamethasone; Inf: Infliximab; Mag-50: Magliasa at a dose of 50 mg/kg; Mag-100: Magliasa at a dose of 100 mg/kg; Mag-200: Magliasa at a dose of 200 mg/kg.